Barbara Ryan

Articles

Biopharma’s Reputation Gets a Well-Earned Shot in the Arm

Amid vaccine heroics, its complex story may finally be resonating.

The Best and the Worst on Display in Vaccine Effort

Dueling paths leave market fortunes uncertain.

JPM Conference Goes Virtual: What Will it Mean?

Tone still set on the market catalysts to look for in 2021.

For Investors, ’Tis the Season to be Grateful

Vaccine strides, likely pricing impasse point to optimism for 2021.